Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Rohit R. Nathani, Stephanie M. Rutledge, Carolina S. Villarroel, Ron Shapiro, Sander S. Florman, Fasika M. Tedla, Thomas D. Schiano, Gene Y. Im
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867020320267829248
author Rohit R. Nathani
Stephanie M. Rutledge
Carolina S. Villarroel
Ron Shapiro
Sander S. Florman
Fasika M. Tedla
Thomas D. Schiano
Gene Y. Im
author_facet Rohit R. Nathani
Stephanie M. Rutledge
Carolina S. Villarroel
Ron Shapiro
Sander S. Florman
Fasika M. Tedla
Thomas D. Schiano
Gene Y. Im
Rohit R. Nathani
Stephanie M. Rutledge
Carolina S. Villarroel
Ron Shapiro
Sander S. Florman
Fasika M. Tedla
Thomas D. Schiano
Gene Y. Im
collection Wiley Open Access
contents Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study Rohit R. Nathani Stephanie M. Rutledge Carolina S. Villarroel Ron Shapiro Sander S. Florman Fasika M. Tedla Thomas D. Schiano Gene Y. Im Clinical Transplantation AbstractBackgroundGuidelines recommend kidney transplant alone (KTA) in compensated cirrhosis based on a few small studies, but this is not widely performed despite its potential benefit to patients and the organ supply. Our aim was to determine the outcomes of KTA in patients with compensated cirrhosis.Study designFrom 1/2012 to 12/2021, outcomes in KTA recipients with compensated cirrhosis were retrospectively compared to patients with chronic liver disease (CLD) but no cirrhosis. Patients with compensated cirrhosis were also compared to a matched cohort (based on age, time on hemodialysis, sex, and ethnicity) of KTA recipients without CLD. The outcomes included patient survival, allograft failure, allograft rejection, serious infection, liver decompensation, and length of stay (LOS).ResultsOver 9 years, 1562 KTAs were performed, with 150 (9.6%) patients having CLD mostly due to chronic hepatitis C, and a median follow‐up of 3.5 years. 32/150 (21%) had compensated cirrhosis at the time of KTA with a mean MELD‐Na of 22 (1.5). Matched controls (n = 189) were identified. We found no differences in patient survival (p = .07), allograft failure (p = .6), allograft rejection (p = .43), rates of serious infection (p = .31), as well as LOS (p = .61) among patients with compensated cirrhosis compared to patients with CLD but no cirrhosis, but with higher rates of liver decompensation (p = .004). Similarly, compared to patients without CLD, patients with cirrhosis had similar rates of patient survival (p = .20), allograft failure (p = .27), allograft rejection (p = .62) and LOS (p = .19) but with higher rates of serious infections (p = .001).ConclusionsOur study supports the safety and efficacy of KTA in patients with compensated cirrhosis. 10.1111/ctr.15259 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/ctr.15259
format Artículo Open Access
id wiley_oa_10_1111_ctr_15259
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study
Rohit R. Nathani
Stephanie M. Rutledge
Carolina S. Villarroel
Ron Shapiro
Sander S. Florman
Fasika M. Tedla
Thomas D. Schiano
Gene Y. Im
Clinical Transplantation
Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study Rohit R. Nathani Stephanie M. Rutledge Carolina S. Villarroel Ron Shapiro Sander S. Florman Fasika M. Tedla Thomas D. Schiano Gene Y. Im Clinical Transplantation AbstractBackgroundGuidelines recommend kidney transplant alone (KTA) in compensated cirrhosis based on a few small studies, but this is not widely performed despite its potential benefit to patients and the organ supply. Our aim was to determine the outcomes of KTA in patients with compensated cirrhosis.Study designFrom 1/2012 to 12/2021, outcomes in KTA recipients with compensated cirrhosis were retrospectively compared to patients with chronic liver disease (CLD) but no cirrhosis. Patients with compensated cirrhosis were also compared to a matched cohort (based on age, time on hemodialysis, sex, and ethnicity) of KTA recipients without CLD. The outcomes included patient survival, allograft failure, allograft rejection, serious infection, liver decompensation, and length of stay (LOS).ResultsOver 9 years, 1562 KTAs were performed, with 150 (9.6%) patients having CLD mostly due to chronic hepatitis C, and a median follow‐up of 3.5 years. 32/150 (21%) had compensated cirrhosis at the time of KTA with a mean MELD‐Na of 22 (1.5). Matched controls (n = 189) were identified. We found no differences in patient survival (p = .07), allograft failure (p = .6), allograft rejection (p = .43), rates of serious infection (p = .31), as well as LOS (p = .61) among patients with compensated cirrhosis compared to patients with CLD but no cirrhosis, but with higher rates of liver decompensation (p = .004). Similarly, compared to patients without CLD, patients with cirrhosis had similar rates of patient survival (p = .20), allograft failure (p = .27), allograft rejection (p = .62) and LOS (p = .19) but with higher rates of serious infections (p = .001).ConclusionsOur study supports the safety and efficacy of KTA in patients with compensated cirrhosis. 10.1111/ctr.15259 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study
topic Clinical Transplantation
url https://onlinelibrary.wiley.com/doi/10.1111/ctr.15259